News Archive

Investigators were unsure how they would use genetic information to choose treatment choices, then often failed to follow through on their pre-stipulated plan to use this information.

The team used pharmacokinetic modeling to assess how the drug would behave in children, leading to FDA approval without conducting a pediatric clinical trial.

Researchers examined clinical factors at the time of a patient’s enrollment in the IPF-PRO registry that might predict lung transplant or death.

The ARISTOTLE study found that apixaban was superior to warfarin in preventing stroke and decreasing risk of bleeding for patients with atrial fibrillation.

The DCRI’s Adrian Hernandez, MD, MHS, and Manesh Patel, MD, will serve as Duke’s representatives to the consortium.

The DCRI will bring its regulatory experience and clinical expertise to the conversation surrounding digital therapeutics.

Patients tend to be sicker and miss full benefits by the time palliative care is provided.

The program, offered by the American College of Cardiology, will see involvement from DCRI faculty in chairing, teaching, and participating.

The DCRI was recognized in five categories, including Capabilities, Compatibility, Expertise, Phase IV, and Reliability.

Through projects such as ADAPTABLE, CTTI, and the NIH Collaboratory, the DCRI is defining how to use RWE in clinical research.